Quick Answer
UTAH MEDICAL PRODUCTS INC reported Total Revenue of $38.52 million for the year ending 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -5.8% in Total Revenue from 2024 to 2025.
- This data is from UTAH MEDICAL PRODUCTS INC's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2017: $10.20 million | Q1 2018: $10.89 million | Q2 2018: $10.97 million | Q3 2018: $10.39 million | Q4 2018: $9.76 million | Q1 2019: $10.73 million | Q2 2019: $11.85 million | Q3 2019: $12.49 million | Q4 2019: $11.83 million | Q1 2020: $10.90 million | Q2 2020: $8.79 million | Q3 2020: $10.48 million | Q4 2020: $12.01 million | Q1 2021: $10.96 million | Q2 2021: $12.60 million | Q3 2021: $12.57 million | Q4 2021: $12.91 million | Q1 2022: $12.32 million | Q2 2022: $13.43 million | Q3 2022: $12.96 million | Q4 2022: $13.58 million | Q1 2023: $12.52 million | Q2 2023: $12.87 million | Q3 2023: $12.51 million | Q4 2023: $12.33 million | Q1 2024: $11.34 million | Q2 2024: $10.40 million | Q3 2024: $10.01 million | Q4 2024: $9.16 million | Q1 2025: $9.71 million | Q2 2025: $9.95 million | Q3 2025: $9.81 million | Q4 2025: $9.04 million.
- Over the full 10 years of available data (2016 to 2025), UTAH MEDICAL PRODUCTS INC's Total Revenue has declined by 2.0%.
- Historical annual values: Fiscal year 2025: $38.52 million | Fiscal year 2024: $40.90 million | Fiscal year 2023: $50.22 million | Fiscal year 2022: $52.28 million | Fiscal year 2021: $49.05 million | Fiscal year 2020: $42.18 million | Fiscal year 2019: $46.90 million | Fiscal year 2018: $42.00 million | Fiscal year 2017: $41.41 million | Fiscal year 2016: $39.30 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: